{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:27:33Z","timestamp":1790195253134,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Critically ill patients admitted to the intensive care unit (ICU) frequently suffer from sepsis and severe multiple organ dysfunction with underlying widespread cell death. Pyroptosis and ferroptosis are regulated cell death forms that may serve as potential therapeutic targets. Pyroptosis is a major detrimental factor driving sepsis, which typically results in excessive oxidative stress potentially inducing ferroptotic organ injury. Here, we show that ICU patients with simultaneous pyro- and ferroptosis-positive signatures have the lowest survival probability. This is reflected by significantly elevated levels of pyroptosis-related biomarkers interleukin-1 receptor antagonist (IL-1Ra), IL-18, and growth and differentiation factor-15 (GDF15), as well as the ferroptosis-related biomarkers malondialdehyde (MDA) and catalytic iron (Fe\n                    <jats:sub>c<\/jats:sub>\n                    ). Moreover, combining these biomarkers with IL-1\u03b1, IL-6, IL-10, TNF, and chitinase-3-like protein 1 further improves clinical outcome prediction. The daily monitoring of pyro- and ferroptosis signatures reveals potential intervention opportunities, such as anakinra, tadekinig alfa, lead ferroptosis inhibitors, or a combination thereof. In summary, our findings demonstrate that a targeted biomarker panel enables predictive enrichment of ICU patients, paving the way for timely intervention strategies against pyroptosis or ferroptosis.\n                  <\/jats:p>","DOI":"10.1038\/s41418-025-01545-0","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T01:54:57Z","timestamp":1752890097000},"page":"2284-2293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Potential of biomarker-based enrichment strategies to identify critically ill patients for emerging cell death interventions"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8425-7707","authenticated-orcid":false,"given":"Cyril","family":"Willemart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Seurinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Stroobants","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samya","family":"Van Coillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorien","family":"De Loor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Men","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ria","family":"Roelandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Rajapurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Symen","family":"Ligthart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe G.","family":"Jorens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique D.","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Saeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9301-8055","authenticated-orcid":false,"given":"Eric","family":"Hoste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1633-0974","authenticated-orcid":false,"given":"Tom","family":"Vanden Berghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"1545_CR1","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1056\/NEJMp1707170","volume":"377","author":"K Reinhart","year":"2017","unstructured":"Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing sepsis as a global health priority - A WHO Resolution. N Engl J Med. 2017;377:414\u20137.","journal-title":"N Engl J Med"},{"key":"1545_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840\u201351.","journal-title":"N Engl J Med"},{"key":"1545_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2478-6","volume":"23","author":"JL Vincent","year":"2019","unstructured":"Vincent JL, Jones G, David S, Olariu E, Cadwell KK. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care. 2019;23:196.","journal-title":"Crit Care"},{"key":"1545_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41418-018-0196-2","volume":"26","author":"T Vanden Berghe","year":"2019","unstructured":"Vanden Berghe T, Hoste E. Paving the way for precision medicine v2.0 in intensive care by profiling necroinflammation in biofluids. Cell Death Differ. 2019;26:83\u201398.","journal-title":"Cell Death Differ"},{"key":"1545_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00134-021-06587-9","volume":"48","author":"A Granholm","year":"2022","unstructured":"Granholm A, Alhazzani W, Derde LPG, Angus DC, Zampieri FG, Hammond NE, et al. Randomised clinical trials in critical care: past, present and future. Intensive Care Med. 2022;48:164\u201378.","journal-title":"Intensive Care Med"},{"key":"1545_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104318","volume":"86","author":"JL Vincent","year":"2022","unstructured":"Vincent JL. Current sepsis therapeutics. EBioMedicine. 2022;86:104318.","journal-title":"EBioMedicine"},{"key":"1545_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccc.2019.08.002","volume":"36","author":"SM Opal","year":"2020","unstructured":"Opal SM, Wittebole X. Biomarkers of Infection and Sepsis. Crit Care Clin. 2020;36:11\u201322.","journal-title":"Crit Care Clin"},{"key":"1545_CR8","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1038\/s41418-023-01204-2","volume":"30","author":"C Peleman","year":"2023","unstructured":"Peleman C, Van Coillie S, Ligthart S, Choi SM, De Waele J, Depuydt P, et al. Ferroptosis and pyroptosis signatures in critical COVID-19 patients. Cell Death Differ. 2023;30:2066\u201377.","journal-title":"Cell Death Differ"},{"key":"1545_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1136\/thorax-2023-220538","volume":"79","author":"DB Antcliffe","year":"2024","unstructured":"Antcliffe DB, Mi Y, Santhakumaran S, Burnham KL, Prevost AT, Ward JK, et al. Patient stratification using plasma cytokines and their regulators in sepsis: relationship to outcomes, treatment effect and leucocyte transcriptomic subphenotypes. Thorax. 2024;79:515\u201323.","journal-title":"Thorax"},{"key":"1545_CR10","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383:2255\u20132273.","journal-title":"N Engl J Med"},{"key":"1545_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41420-023-01766-7","volume":"9","author":"M Cao","year":"2023","unstructured":"Cao M, Wang G, Xie J. Immune dysregulation in sepsis: experiences, lessons and perspectives. Cell Death Discov. 2023;9:465.","journal-title":"Cell Death Discov"},{"key":"1545_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07689-5","volume":"22","author":"Y Li","year":"2022","unstructured":"Li Y, Li H, Guo J, Wang Y, Zhang D. Coupled plasma filtration adsorption for the treatment of sepsis or septic shock: a systematic review and meta-analysis. BMC Infect Dis. 2022;22:714.","journal-title":"BMC Infect Dis"},{"key":"1545_CR13","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201810128","volume":"12","author":"JM Cavaillon","year":"2020","unstructured":"Cavaillon JM, Singer M, Skirecki T. Sepsis therapies: learning from 30 years of failure of translational research to propose new leads. EMBO Mol Med. 2020;12:e10128.","journal-title":"EMBO Mol Med"},{"key":"1545_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, et al. Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial. Crit Care Med. 2016;44:275\u201381.","journal-title":"Crit Care Med"},{"key":"1545_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/CCM.0000000000002749","volume":"46","author":"NJ Meyer","year":"2018","unstructured":"Meyer NJ, Reilly JP, Anderson BJ, Palakshappa JA, Jones TK, Dunn TG, et al. Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration. Crit Care Med. 2018;46:21\u20138.","journal-title":"Crit Care Med"},{"key":"1545_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1347401","volume":"14","author":"CS Yang","year":"2023","unstructured":"Yang CS, Coopersmith CM, Lyons JD. Cell death proteins in sepsis: key players and modern therapeutic approaches. Front Immunol. 2023;14:1347401.","journal-title":"Front Immunol"},{"key":"1545_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/SHK.0000000000001936","volume":"57","author":"M Qu","year":"2022","unstructured":"Qu M, Wang Y, Qiu Z, Zhu S, Guo K, Chen W, et al. Necroptosis, Pyroptosis, Ferroptosis in Sepsis and Treatment. Shock. 2022;57:161\u201371.","journal-title":"Shock"},{"key":"1545_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1164\/rccm.201308-1535OC","volume":"189","author":"T Vanden Berghe","year":"2014","unstructured":"Vanden Berghe T, Demon D, Bogaert P, Vandendriessche B, Goethals A, et al. Simultaneous targeting of IL-1 and IL-18 is required for protection against inflammatory and septic shock. Am J Respir Crit Care Med. 2014;189:282\u201391.","journal-title":"Am J Respir Crit Care Med"},{"key":"1545_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-022-00488-x","volume":"11","author":"SMT Nasser","year":"2023","unstructured":"Nasser SMT, Rana AA, Doffinger R, Kafizas A, Khan TA, Nasser S. Elevated free interleukin-18 associated with severity and mortality in prospective cohort study of 206 hospitalised COVID-19 patients. Intensive Care Med Exp. 2023;11:9.","journal-title":"Intensive Care Med Exp"},{"key":"1545_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28718-6","volume":"13","author":"S Van Coillie","year":"2022","unstructured":"Van Coillie S, Van San E, Goetschalckx I, Wiernicki B, Mukhopadhyay B, Tonnus W, et al. Targeting ferroptosis protects against experimental (multi)organ dysfunction and death. Nat Commun. 2022;13:1046.","journal-title":"Nat Commun"},{"key":"1545_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1192-x","volume":"20","author":"J De Loor","year":"2016","unstructured":"De Loor J, Decruyenaere J, Demeyere K, Nuytinck L, Hoste EA, Meyer E. Urinary chitinase 3-like protein 1 for early diagnosis of acute kidney injury: a prospective cohort study in adult critically ill patients. Crit Care. 2016;20:38.","journal-title":"Crit Care"},{"key":"1545_CR22","doi-asserted-by":"publisher","first-page":"12281","DOI":"10.1073\/pnas.1918508117","volume":"117","author":"I Santos","year":"2020","unstructured":"Santos I, Colaco HG, Neves-Costa A, Seixas E, Velho TR, Pedroso D, et al. CXCL5-mediated recruitment of neutrophils into the peritoneal cavity of Gdf15-deficient mice protects against abdominal sepsis. Proc Natl Acad Sci USA. 2020;117:12281\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1545_CR23","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1021\/tx9701790","volume":"11","author":"D Gerard-Monnier","year":"1998","unstructured":"Gerard-Monnier D, Erdelmeier I, Regnard K, Moze-Henry N, Yadan JC, Chaudiere J. Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem Res Toxicol. 1998;11:1176\u201383.","journal-title":"Chem Res Toxicol"},{"key":"1545_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1042\/bj1990263","volume":"199","author":"JM Gutteridge","year":"1981","unstructured":"Gutteridge JM, Rowley DA, Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of \u2018free\u2019 iron in biological systems by using bleomycin-dependent degradation of DNA. Biochem J. 1981;199:263\u20135.","journal-title":"Biochem J"},{"key":"1545_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707\u201310.","journal-title":"Intensive Care Med"},{"key":"1545_CR26","doi-asserted-by":"crossref","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE Apache II: A severity of disease classification system. Dimens Critical Care Nurs. 1986;5.","DOI":"10.1097\/00003465-198603000-00013"},{"key":"1545_CR27","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour C, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"1545_CR28","first-page":"S1","volume":"39","author":"National Kidney F","year":"2002","unstructured":"National Kidney F. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1\u2013266.","journal-title":"Am J Kidney Dis"},{"key":"1545_CR29","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","volume":"126","author":"P Schober","year":"2018","unstructured":"Schober P, Boer C, Schwarte LA. Correlation Coefficients: Appropriate Use and Interpretation. Anesth Analg. 2018;126:1763\u20138.","journal-title":"Anesth Analg"},{"key":"1545_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.32614\/RJ-2017-009","volume":"9\/1","author":"S Moritz","year":"2017","unstructured":"Moritz S, Bartz-Beielstein T. ImputeTS: Time Series Missing Value imputation in R. R J. 2017;91:207\u201318.","journal-title":"R J"},{"key":"1545_CR31","doi-asserted-by":"crossref","unstructured":"Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model, 2. print edn. Springer: New York Berlin Heidelberg, 2001.","DOI":"10.1007\/978-1-4757-3294-8"},{"key":"1545_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn M. Building Predictive Models in R Using the caret Package. J Stat Softw. 2008;28:1\u201326.","journal-title":"J Stat Softw"},{"key":"1545_CR33","unstructured":"John CR. MLeval: Machine Learning Model Evaluation. 0.3 ed; 2020."},{"key":"1545_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.32614\/RJ-2016-021","volume":"8","author":"L Scrucca","year":"2016","unstructured":"Scrucca L, Fop M, Murphy TB, Raftery AE. mclust 5: Clustering, Classification and Density Estimation Using Gaussian Finite Mixture Models. R J. 2016;8:289\u2013317.","journal-title":"R J"},{"key":"1545_CR35","doi-asserted-by":"crossref","unstructured":"Scrucca L, Raftery AE. clustvarsel: A package implementing variable selection for gaussian model-based clustering in R. J Stat Softw, 2018;84:1-28.","DOI":"10.18637\/jss.v084.i01"},{"key":"1545_CR36","first-page":"1","volume":"65","author":"C Genolini","year":"2016","unstructured":"Genolini C, Alacoque X, Sentenac M, Arnaud C. kml and kml3d: R packages to cluster longitudinal data. J Stat Softw. 2016;65:1\u201334.","journal-title":"J Stat Softw"},{"key":"1545_CR37","doi-asserted-by":"crossref","unstructured":"Patil I. Visualizations with statistical details: The \u2018ggstatsplot\u2019 approach. J Open Source Softw, 2021;6:3167.","DOI":"10.21105\/joss.03167"},{"key":"1545_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104387","volume":"86","author":"JC Marshall","year":"2022","unstructured":"Marshall JC, Leligdowicz A. Gaps and opportunities in sepsis translational research. EBioMedicine. 2022;86:104387.","journal-title":"EBioMedicine"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01545-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01545-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01545-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T14:39:25Z","timestamp":1764599965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01545-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1545"],"URL":"https:\/\/doi.org\/10.1038\/s41418-025-01545-0","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TVB owns patents related to ferroptosis inhibitors\u00a0and is founder of FiriX Therapeutics. EM owns a patent related to CHI3L1. All other authors declare that they have no financial or non-financial interests related to this manuscript. Please refer to the accompanying ICM JE disclosure forms for further details.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}